Funke, Manuela; Geiser, Thomas (2016). [Anti-fibrotics as novel therapy for idiopathic pulmonary fibrosis]. Therapeutische Umschau, 73(1), pp. 25-29. Huber 10.1024/0040-5930/a000751
Full text not available from this repository. (Request a copy)Recent studies have shown efficacy to slow the decrease of forced vital capacity in patients with idiopathic pulmonary fibrosis. This summary refers to recent anti-fibrotic medications and describes current studies, indication for treatment and side effects, as well as discusses open questions of treatment.
Item Type: |
Journal Article (Further Contribution) |
|---|---|
Division/Institute: |
04 Faculty of Medicine > Department of Gastro-intestinal, Liver and Lung Disorders (DMLL) > Clinic of Pneumology |
UniBE Contributor: |
Funke, Manuela, Geiser, Thomas (A) |
Subjects: |
600 Technology > 610 Medicine & health |
ISSN: |
0040-5930 |
Publisher: |
Huber |
Language: |
German |
Submitter: |
Rahel Holderegger |
Date Deposited: |
22 Mar 2017 15:28 |
Last Modified: |
29 Mar 2023 23:35 |
Publisher DOI: |
10.1024/0040-5930/a000751 |
PubMed ID: |
26884217 |
URI: |
https://boris.unibe.ch/id/eprint/93081 |
Actions (login required)
 |
Edit item |